₹ 6.69
-0.05 (-0.74%)
BSE
V
Vista Pharmaceuticals
₹ 6.69
BSE
Vista Pharmaceuticals EPS Summary
The latest quarterly EPS of Vista Pharmaceuticals as of Q1 Jun 2026 stands at ₹-0.16. This is a 82.42% growth quarter on quarter and 27.27% growth same quarter last year. For the FY2026 the EPS of Vista Pharmaceuticals stands at ₹-1.96. This is a 148.10% fall compared with FY2025.
Vista Pharmaceuticals EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

